IL93298A - Pharmaceutical compositions comprising cyclosporin - Google Patents

Pharmaceutical compositions comprising cyclosporin

Info

Publication number
IL93298A
IL93298A IL93298A IL9329890A IL93298A IL 93298 A IL93298 A IL 93298A IL 93298 A IL93298 A IL 93298A IL 9329890 A IL9329890 A IL 9329890A IL 93298 A IL93298 A IL 93298A
Authority
IL
Israel
Prior art keywords
component
components
composition
solvent
respect
Prior art date
Application number
IL93298A
Other versions
IL93298A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898902901A external-priority patent/GB8902901D0/en
Priority claimed from GB898902898A external-priority patent/GB8902898D0/en
Priority claimed from GB898903147A external-priority patent/GB8903147D0/en
Priority claimed from GB898903663A external-priority patent/GB8903663D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL93298A0 publication Critical patent/IL93298A0/en
Publication of IL93298A publication Critical patent/IL93298A/en

Links

Abstract

Pharmaceutical compositions comprising (a) a cyclosporin as active ingredient, (b) a fatty acid saccharide monoester and (c) a diluent or carrier, whereby (i) component (c) is a solvent with respect to both components (a) and (b), components (a) and (b) each independently having a solubility in component (c) of at least 10% at ambient temperature; or (ii) component (c) is a solvent with respect to both components (a) and (b), and components (a) and (c) are present in said composition in a ratio of 1:0.5 to 50 p.p.w. £(a):(c)|; or (iii) component (c) is a solvent with respect to both components (a) and (b) and said composition is formulated in solid unit dosage form suitable for oral administration; or (iv) component (c) comprises a poly- (C2-4 alkylene) -glycol having an average molecular weight of at most 7,000 or a viscosity at 50oC at ambient temperature of at most 15,000 mPa.s. or comprises a C3-5 alkylene polylol ether or ester; or (v) said composition is or is substantially, non-aqueous; or (vi) component (c) comprises a solid polymeric carrier, an organosilicon oxide polymer or paraffinum per-or sub-liquidum and component (a) is present in said composition in solid solution in (b).
IL93298A 1989-02-09 1990-02-07 Pharmaceutical compositions comprising cyclosporin IL93298A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB898902901A GB8902901D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB898902898A GB8902898D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB898903147A GB8903147D0 (en) 1989-02-13 1989-02-13 Improvements in or relating to organic compounds
GB898903663A GB8903663D0 (en) 1989-02-17 1989-02-17 Improvements in or relating to organic compounds
IL8774690 1990-02-07

Publications (2)

Publication Number Publication Date
IL93298A0 IL93298A0 (en) 1990-11-29
IL93298A true IL93298A (en) 1997-06-10

Family

ID=27516887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93298A IL93298A (en) 1989-02-09 1990-02-07 Pharmaceutical compositions comprising cyclosporin

Country Status (1)

Country Link
IL (1) IL93298A (en)

Also Published As

Publication number Publication date
IL93298A0 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
CA1210701A (en) High foaming liquid shampoo composition
KR900012625A (en) Cyclosporingane formulations
US4678664A (en) Mineral oil gels
CA2039518A1 (en) Cosmetic gel stick compositions
UA27707C2 (en) Prolonged release preparation, polymer base used in prolonged release pharmaceutic preparations and process for preparation thereof
FI972366A (en) Lipopolyamines as transfecting agents and their pharmaceutical use
KR890001521A (en) Sustained Release New Pharmaceutical Formulations
DE69725862D1 (en) HIGH MOLECULAR WEIGHT BASED MEDICINE PREPARATIONS
FI880163A (en) Method for preparing a solution for use as a medicament
AU648055B2 (en) Washing compositions based on insoluble silicones and on a surface-active agent of the polyoxyalkylenated carboxylic ether acid type, and their application in cosmetics and in dermatology
NZ508301A (en) Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polyethylene glycol, and polyorthoester-polyethylene glycol-polyorthoester block copolymers
NZ512287A (en) Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
AU3909400A (en) Propofol formulation containing tris
IT1141625B (en) NON-IONIC SURFACTANTS PROCEDURE FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
MY101844A (en) Water-soluble viscosity increasing agent and detergent composition containing the same.
DE69123661T2 (en) New surfactant compositions, processes for their preparation and pesticidal compositions containing them
GEP20012547B (en) Oral Cyclosporin Formulation
US4544495A (en) High foaming liquid shampoo composition
SE451666B (en) STABLE BENZOYL PEROXIDE COMPOSITION
IL93298A (en) Pharmaceutical compositions comprising cyclosporin
EP1002546B1 (en) Use of esters of 12-hydroxystearic acid as solubilizers
US4359478A (en) Hypocholesterolaemic agents
CA2251702A1 (en) Biologically active composition
IE56369B1 (en) Anthelmintic gel compositions and a method for their preparation at ambient temperatures
JPH11347394A (en) Use of fatty acid derivative and aliphalic alcohol derivative polymerized as solubilizing agent and pharmacological preparation containing those derivatives, cosmetic preparation and food preparation

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees